These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27032418)

  • 21. The evolving paradigm of cell-nonautonomous UPR-based regulation of immunity by cancer cells.
    Zanetti M; Rodvold JJ; Mahadevan NR
    Oncogene; 2016 Jan; 35(3):269-78. PubMed ID: 25893303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research.
    ; Van Deun J; Mestdagh P; Agostinis P; Akay Ö; Anand S; Anckaert J; Martinez ZA; Baetens T; Beghein E; Bertier L; Berx G; Boere J; Boukouris S; Bremer M; Buschmann D; Byrd JB; Casert C; Cheng L; Cmoch A; Daveloose D; De Smedt E; Demirsoy S; Depoorter V; Dhondt B; Driedonks TA; Dudek A; Elsharawy A; Floris I; Foers AD; Gärtner K; Garg AD; Geeurickx E; Gettemans J; Ghazavi F; Giebel B; Kormelink TG; Hancock G; Helsmoortel H; Hill AF; Hyenne V; Kalra H; Kim D; Kowal J; Kraemer S; Leidinger P; Leonelli C; Liang Y; Lippens L; Liu S; Lo Cicero A; Martin S; Mathivanan S; Mathiyalagan P; Matusek T; Milani G; Monguió-Tortajada M; Mus LM; Muth DC; Németh A; Nolte-'t Hoen EN; O'Driscoll L; Palmulli R; Pfaffl MW; Primdal-Bengtson B; Romano E; Rousseau Q; Sahoo S; Sampaio N; Samuel M; Scicluna B; Soen B; Steels A; Swinnen JV; Takatalo M; Thaminy S; Théry C; Tulkens J; Van Audenhove I; van der Grein S; Van Goethem A; van Herwijnen MJ; Van Niel G; Van Roy N; Van Vliet AR; Vandamme N; Vanhauwaert S; Vergauwen G; Verweij F; Wallaert A; Wauben M; Witwer KW; Zonneveld MI; De Wever O; Vandesompele J; Hendrix A
    Nat Methods; 2017 Feb; 14(3):228-232. PubMed ID: 28245209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular vesicles in the tumour microenvironment.
    Carter DRF; Clayton A; Devitt A; Hunt S; Lambert DW
    Philos Trans R Soc Lond B Biol Sci; 2018 Jan; 373(1737):. PubMed ID: 29158307
    [No Abstract]   [Full Text] [Related]  

  • 24. Interaction of MSC with tumor cells.
    Melzer C; Yang Y; Hass R
    Cell Commun Signal; 2016 Sep; 14(1):20. PubMed ID: 27608835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular vesicle-mediated transfer of processed and functional RNY5 RNA.
    Chakrabortty SK; Prakash A; Nechooshtan G; Hearn S; Gingeras TR
    RNA; 2015 Nov; 21(11):1966-79. PubMed ID: 26392588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratumor heterogeneity: origins, clinical significance and optimal strategies for cancer treatment.
    Mangano A; Lianos GD; Mangano A; Boni L; Dionigi G
    Future Oncol; 2015; 11(4):561-4. PubMed ID: 25686113
    [No Abstract]   [Full Text] [Related]  

  • 27. PML-RARa modulates the vascular signature of extracellular vesicles released by acute promyelocytic leukemia cells.
    Fang Y; Garnier D; Lee TH; D'Asti E; Montermini L; Meehan B; Rak J
    Angiogenesis; 2016 Jan; 19(1):25-38. PubMed ID: 26374632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential diagnostic power of extracellular vesicle analysis for multiple myeloma.
    Canella A; Harshman SW; Radomska HS; Freitas MA; Pichiorri F
    Expert Rev Mol Diagn; 2016; 16(3):277-84. PubMed ID: 26671731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular vesicles derived from renal cancer stem cells induce a pro-tumorigenic phenotype in mesenchymal stromal cells.
    Lindoso RS; Collino F; Camussi G
    Oncotarget; 2015 Apr; 6(10):7959-69. PubMed ID: 25797265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The challenge of intratumour heterogeneity in precision medicine.
    Seoane J; De Mattos-Arruda L
    J Intern Med; 2014 Jul; 276(1):41-51. PubMed ID: 24661605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular vesicle-mediated modulation of angiogenesis.
    Gai C; Carpanetto A; Deregibus MC; Camussi G
    Histol Histopathol; 2016 Apr; 31(4):379-91. PubMed ID: 26662176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-derived microvesicles in the tumor microenvironment: How vesicle heterogeneity can shape the future of a rapidly expanding field.
    Clancy JW; Tricarico CJ; D'Souza-Schorey C
    Bioessays; 2015 Dec; 37(12):1309-16. PubMed ID: 26439878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity.
    Albini A; Bruno A; Gallo C; Pajardi G; Noonan DM; Dallaglio K
    Connect Tissue Res; 2015; 56(5):414-25. PubMed ID: 26291921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miRNA Deregulation in Cancer Cells and the Tumor Microenvironment.
    Rupaimoole R; Calin GA; Lopez-Berestein G; Sood AK
    Cancer Discov; 2016 Mar; 6(3):235-46. PubMed ID: 26865249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular Vesicles as Biomarkers and Therapeutic Targets in Breast Cancer.
    Sadovska L; Eglītis J; Linē A
    Anticancer Res; 2015 Dec; 35(12):6379-90. PubMed ID: 26637847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression.
    Giussani M; Merlino G; Cappelletti V; Tagliabue E; Daidone MG
    Semin Cancer Biol; 2015 Dec; 35():3-10. PubMed ID: 26416466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfer of microRNAs by extracellular membrane microvesicles: a nascent crosstalk model in tumor pathogenesis, especially tumor cell-microenvironment interactions.
    Zhang L; Valencia CA; Dong B; Chen M; Guan PJ; Pan L
    J Hematol Oncol; 2015 Feb; 8():14. PubMed ID: 25885907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors.
    Lorz A; Lorenzi T; Clairambault J; Escargueil A; Perthame B
    Bull Math Biol; 2015 Jan; 77(1):1-22. PubMed ID: 25480478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment.
    Justus CR; Sanderlin EJ; Yang LV
    Int J Mol Sci; 2015 May; 16(5):11055-86. PubMed ID: 25988385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. microRNAs and Prostate Cancer.
    Josson S; Chung LW; Gururajan M
    Adv Exp Med Biol; 2015; 889():105-18. PubMed ID: 26658999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.